Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)

Trial Profile

Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)

Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin; Bivalirudin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Biomarker; Pharmacodynamics
  • Acronyms RAPID2
  • Most Recent Events

    • 06 Oct 2015 Status is changed from recruiting to completed as per CT.gov
    • 18 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top